(Q50961020)

26 March 2018

title

Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. (English)

1 reference

26 March 2018

main subject

phase III clinical trial

0 references

author

Marie-Rose Christiaens

5

object named as

Marie-Rose Christiaens

1 reference

26 March 2018

Emiel Rutgers

4

object named as

Emiel Rutgers

1 reference

26 March 2018

author name string

Saskia Litière

1

1 reference

26 March 2018

Gustavo Werutsky

2

1 reference

26 March 2018

Ian S Fentiman

3

1 reference

26 March 2018

Erik Van Limbergen

6

1 reference

26 March 2018

Margreet H A Baaijens

7

1 reference

26 March 2018

Jan Bogaerts

8

1 reference

26 March 2018

Harry Bartelink

9

1 reference

26 March 2018

publication date

27 February 2012

1 reference

26 March 2018

Lancet Oncology Commission

published in

1 reference

26 March 2018

volume

13

1 reference

26 March 2018

issue

4

1 reference

26 March 2018

page(s)

412-419

1 reference

26 March 2018

Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Quality indicators for breast cancer: revisiting historical evidence in the context of technology changes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Breast-conserving surgery and radiotherapy in early-stage breast cancer: the importance of local control

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Consensus Statement on postmastectomy radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Predicting a local recurrence after breast-conserving therapy by gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Local recurrence after breast-conserving therapy in relation to gene expression patterns in a large series of patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Breast cancer subtypes and the risk of local and regional relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

Early-stage young breast cancer patients: impact of local treatment on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2812%2970042-6

7 January 2021

10.1016/S1470-2045(12)70042-6

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018